Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned. Reply from the authors

Br J Dermatol. 2020 Dec;183(6):1153-1154. doi: 10.1111/bjd.19491. Epub 2020 Sep 20.

Authors

I Colmenero¹, C Santonja², M Alonso-Riaño¹, D Andina³, J L Rodríguez-Peralto¹, L Requena⁴, A Torrelo⁵

Affiliations

¹ Department of Pathology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
² Department of Pathology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
³ Emergency Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
⁴ Department of Dermatology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
⁵ Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

Abstract

Linked Articles: Baeck et al. Br J Dermatol 2020; 183:1152–1153. Colmenero et al. Br J Dermatol 2020; 183:729–737

Publication types

Letter
Comment

MeSH terms

COVID-19*
Chilblains*
Humans
Risk Factors
SARS-CoV-2